Panagora Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-356,740	Closed	-$1.33M	–	1219
2023 Q4	$1.33M	Sell	356,740 -69,845	-16%	-$165K	0.01%	709
2023 Q3	$904K	Buy	426,585 +107,098	+34%	+$355K	0.01%	808
2023 Q2	$1.52M	Sell	319,487 -5,874	-2%	-$32.4K	0.01%	644
2023 Q1	$1.85M	Buy	325,361 +5,041	+2%	+$30.4K	0.01%	597
2022 Q4	$3.23M	Buy	320,320 +22,042	+7%	+$414K	0.02%	481
2022 Q3	$6.68M	Sell	298,278 -2,374	-0.8%	-$68.6K	0.05%	301
2022 Q2	$7.45M	Buy	300,652 +25,207	+9%	+$695K	0.05%	301
2022 Q1	$10.7M	Buy	275,445 +616	+0.2%	+$23.9K	0.06%	278
2021 Q4	$16.1M	Buy	274,829 +9,456	+4%	+$536K	0.09%	217
2021 Q3	$15.7M	Buy	265,373 +33,473	+14%	+$2.63M	0.08%	224
2021 Q2	$20.1M	Buy	231,900 +69,304	+43%	+$5.58M	0.11%	193
2021 Q1	$13.4M	Buy	+162,596	New	+$15.6M	0.08%	245
2018 Q3	–	Sell	-6,275	Closed	-$71K	–	2426
2018 Q2	$71K	Sell	6,275 -4,964	-44%	-$54.7K	﹤0.01%	1958
2018 Q1	$110K	Sell	11,239 -12,224	-52%	-$117K	﹤0.01%	1832
2017 Q4	$143K	Sell	23,463 -32	-0.1%	-$143	﹤0.01%	1775
2017 Q3	$93K	Sell	23,495 -6,015	-20%	-$20.5K	﹤0.01%	1906
2017 Q2	$96K	Hold	29,510	–	–	﹤0.01%	1886
2017 Q1	$134K	Hold	29,510	–	–	﹤0.01%	1778
2016 Q4	$74K	Hold	29,510	–	–	﹤0.01%	2019
2016 Q3	$92K	Buy	+29,510	New	+$71.6K	﹤0.01%	1987

Other funds holding FATE